The objective of this pilot study is to provide information about the usefulness of NIRS in the study of patients with JDM in the test configuration as described in the protocol. For this purpose, the microvascular oxygenation and hemodynamics in…
ID
Source
Brief title
Condition
- Autoimmune disorders
- Muscle disorders
- Vascular disorders NEC
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
The following main study parameters will be continuously determined with NIRS
in the VM and VL muscle of the dominant leg:
- Change in concentration deoxygenated hemoglobin (µM)
- Change in concentration oxygenated hemoglobin (µM)
- Change in concentration total hemoglobin (µM)
- Change in concentration deoxygenated hemoglobin minus change in concentration
oxygenated hemoglobin (µM)
The following study parameters are sole values that will be determined from the
CPET:
- Relative peak oxygen consumption as percentage of predicted (%)
- Ventilatory anaerobic threshold as percentage of predicted relative peak
oxygen consumption (%)
- Peak power output as percentage of predicted (%)
- Oxygen uptake to work rate slope (ml O2 /Watt)
The T1/2 (s) will be determined from the change in oxygenated hemoglobin
concentration data from the VM and VL muscle of the dominant leg in the
recovery phase.
Secondary outcome
Not applicable.
Background summary
Juvenile dermatomyositis (JDM) is an idiopathic chronic auto-immune disease in
childhood in which the microvasculature of the skin and skeletal muscles is
targeted by the immune system. This results in reduced exercise tolerance due
to abnormally thickened endothelial walls of the intermuscular capillaries,
arterioles, and veins, decreased capillary bed volume, and impaired perfusion
in muscles (1-7).
For the assessment of the clinical course of the disease and for the
evaluation of the effects of interventions and therapies, it is important to
have an objective longitudinal perspective. Since the cause of the exercise
intolerance in JDM is thought to be situated in the microvasculature of muscle
tissue, near infrared spectroscopy (NIRS) could be a possible tool for this
need. In previous studies, it was shown that it is possible to detect with NIRS
abnormal muscle oxygenation patterns during exercise and recovery in patients
with different levels of exercise intolerance (8). However, the application of
NIRS during exercise and recovery in the study of children with dermatomyositis
is not determined at present.
In the proposed pilot study, NIRS measurements will be combined with a
cardiopulmonary exercise test (CPET) on a cycle ergometer. NIRS measurements
will be done on the vastus medialis (VM) and vastus lateralis (VL) muscle
during a single test. The data of patients with JDM will be compared with those
of age- and gender matched patients with juvenile idiopathic arthritis (JIA)
and healthy children.
Study objective
The objective of this pilot study is to provide information about the
usefulness of NIRS in the study of patients with JDM in the test configuration
as described in the protocol. For this purpose, the microvascular oxygenation
and hemodynamics in thigh muscle of patients with JDM and subjects in the
control groups will be qualitatively assessed during rest, incremental
exercise, and recovery with continuous wave NIRS. In this way, abnormal
features could be observed. Furthermore, the microvascular function of the
muscle will be quantitatively assessed by calculation of the half-recovery time
of deoxygenated hemoglobin (T1/2) during recovery. This parameter is related to
microvascular function. These values will be compared with those of patients
with JIA and healthy subjects.
Since it is thought that patients with JDM have impaired perfusion in
muscle tissue, it is hypothesised that patients with JDM show a higher T1/2.
Moreover, the T1/2 values will be linked with other measures obtained during
the CPET. Finally, microvascular oxygenation response data obtained from the VM
and VL muscle will be compared to each other. Together, these examinations
provide information about the usefulness of NIRS in the study of patients with
JDM in the test configuration as described in the protocol.
Study design
In this cross-sectional pilot study, thigh muscles of a heterogeneous
population of patients with JDM, patients with JIA, and healthy young subjects
will be measured during rest, incremental cycling exercise, and recovery with
NIRS.
Study burden and risks
For the healthy children, the load is performing a CPET with NIRS measurements
once only. This test produces interesting results for the children and their
parents. The risks for a CPET are minimal and NIRS measurements are safe as
well. For the patient population, the only additional load is the measurement
done with NIRS.
Children show different physiological responses to exercise compared to
adults. Furthermore, the pathophysiology of dermatomyositis shows differences
between children and adults. For these reasons, it is important to consider
adult and juvenile dermatomyositis separately when studying the application of
NIRS during exercise and recovery in dermatomyositis.
postbus 85090
3508 AB
NL
postbus 85090
3508 AB
NL
Listed location countries
Age
Inclusion criteria
Juvenile dermatomyositis patients: diagnose juvenile dermatomyositis; age between 8 and 18 years; informed consent signature by (the children and) the parents/caregivers.
Juvenile idiopathic arthritis patients: diagnose juvenile idiopathic arthritis; age between 8 and 18 years; informed consent signature by (the children and) the parents/caregivers.
Healthy control subjects: healthy; age between 8 and 18 years; informed consent signature by (the children and) the parents/caregivers.
Exclusion criteria
Juvenile dermatomyositis patients:
Diagnose polymyositis or myositis
Age < 8 years >= 18 years
Medical status that will not allow exercise testing
Insufficient understanding of the Dutch language in both children and parents/caregivers
No informed consent;Juvenile idiopathic arthritis patients:
Age < 8 years >= 18 years
Medical status that will not allow exercise testing
Insufficient understanding of the Dutch language in both children and parents/caregivers
No informed consent;Healthy control subjects:
Age < 8 years >= 18 years
Muscle disease in history
Chronic medication intake
Underlying auto-immune diseases
Medical status that will not allow exercise testing
Insufficient understanding of the Dutch language in both children and parents/caregivers
No informed consent
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL34189.041.10 |